Invesco Ltd. Soleno Therapeutics Inc Transaction History

Invesco Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 17, 2021	SELL	$0.97 - $1.32 $36,876 - $50,182	-38,017 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.24 - $3.3 $2,034 - $5,415	1,641 Added 4.51%	38,017 $48,000
Q4 2020 Feb 16, 2021	BUY	$1.61 - $2.23 $58,565 - $81,118	36,376 New	36,376 $70,000

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $362M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.